Package 13668-202-90

{"route": ["ORAL"], "spl_id": "fe809224-0deb-4a82-b454-054be6dd4931", "openfda": {"upc": ["0313668202304", "0313668203301"], "unii": ["CR02EYQ8GV"], "rxcui": ["485421", "485423"], "spl_set_id": ["e84f1ae3-b9a2-4a15-a299-c75373891cc1"], "manufacturer_name": ["Torrent Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-202-05)", "package_ndc": "13668-202-05", "marketing_start_date": "20161118"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-202-30)", "package_ndc": "13668-202-30", "marketing_start_date": "20161118"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-202-90)", "package_ndc": "13668-202-90", "marketing_start_date": "20161118"}], "brand_name": "Darifenacin", "product_id": "13668-202_fe809224-0deb-4a82-b454-054be6dd4931", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Cholinergic Muscarinic Antagonist [EPC]", "Cholinergic Muscarinic Antagonists [MoA]"], "product_ndc": "13668-202", "generic_name": "Darifenacin", "labeler_name": "Torrent Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Darifenacin", "active_ingredients": [{"name": "DARIFENACIN HYDROBROMIDE", "strength": "7.5 mg/1"}], "application_number": "ANDA205209", "marketing_category": "ANDA", "marketing_start_date": "20161118", "listing_expiration_date": "20271231"}